Specialty
With extensive clinical practice and research experience in the United States, Dr. Ye Gang specializes in the diagnosis and treatment of various cancers and hematologic malignancies, with profound expertise in:
Breast cancer, lung cancer, lymphoma, and multiple myeloma
CAR-T cell therapy for advanced malignancies
In March 2024, Dr. Ye led a team to successfully treat a patient with advanced diffuse large B-cell lymphoma (DLBCL) using Yescarta® (Axicabtagene Ciloleucel Injection), China’s first approved CAR-T cell therapy product. The patient achieved complete metabolic remission (CMR) within one month post-treatment, demonstrating Dr. Ye’s pioneering role in cellular immunotherapy.
The pioneering application of CAR-T therapy at Foshan Fosun Chancheng Hospital provides patients with hematologic malignancies more precise treatment options and higher-quality care, significantly improving their survival rates and quality of life. This initiative ensures patients receive oncology care that is on par with leading international cancer centers.
Dr. Ye Gang is Analyzing the Patient's Condition and Explains the Treatment Methods
Dr. Ye Gang with the Physician and Nurse Team of the Precision Oncology Department
Dr. Ye Gang is Introducing the Hospital's Current Cancer Treatment Methods
Dr. Ye Gang is Sharing Insights with Patients
Dr. Ye Gang Traveled to Bangladesh to Provide Medical Treatment to Patients
